Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polyfunctional antibody signature defines protection in Andes hantavirus survival.

Frontiers in immunology·2026
Same author

Hantavirus infection: A narrative review focusing on epidemiology, diagnosis, infection control and treatment in the era of globalisation.

Medicina intensiva·2026
Same author

Combined Biospectroscopy with Multivariate Analysis for the Differential Diagnosis of Leptospirosis Disease: A Pilot Study.

ACS omega·2026
Same author

Redox metabolism in cell senescence: focusing on contributions from the metabolomic field.

Frontiers in molecular biosciences·2026
Same author

Longitudinal immune profiling uncovers regulatory T cell signatures associated with the progression of COVID-19.

Frontiers in immunology·2026
Same author

Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial.

Nature communications·2025

Related Experiment Video

Updated: May 27, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

[Update. Consensus on ventilator associated pneumonia. Second Part: Prophylaxis].

Mario Calvo1, Luis Delpiano, Eliana Chacón

  • 1Universidad Austral de Chile, Valdivia (MCA). macalvo@uach.cl

Revista Chilena De Infectologia : Organo Oficial De La Sociedad Chilena De Infectologia
|November 5, 2011
PubMed
Summary

Preventing ventilator-associated pneumonia (VAP) in ICUs is crucial. Key strategies include semi-recumbent positioning, oral chlorhexidine care, and orotracheal intubation to reduce patient morbidity and mortality.

More Related Videos

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

Related Experiment Videos

Last Updated: May 27, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

Area of Science:

  • Critical Care Medicine
  • Infectious Disease Prevention
  • Respiratory Therapy

Background:

  • Ventilator-associated pneumonia (VAP) remains a significant cause of morbidity and mortality in intensive care units (ICUs).
  • Advances in treatment necessitate updated prevention strategies to improve patient outcomes.
  • Previous recommendations from 2001 required re-evaluation based on recent scientific literature.

Framework:

  • Evidence-based review of recent scientific literature on VAP prevention.
  • Analysis of strategies including patient positioning, oral care, intubation techniques, and circuit management.
  • Evaluation of cost-effectiveness and efficacy of various interventions.

Implementation:

  • Semi-recumbent patient positioning (45 degrees) is recommended.
  • Routine oral hygiene with chlorhexidine should be incorporated.
  • Preference for orotracheal intubation and subglottic aspiration is advised.
  • Standard hand hygiene and avoiding routine ventilator circuit changes are supported.
  • Bundles for organizing ICU work are recommended.

Implications:

  • Updated guidelines provide a framework for reducing VAP incidence in ICUs.
  • Cost-effective strategies like using heat and moisture exchangers and timely humidification changes are highlighted.
  • Selective digestive decontamination is not recommended due to lack of evidence or applicability.